ο κολπικος υπερηχος δειχνει καρκινο, the direct translation asks if a transvaginal ultrasound can show cancer. Short answer: it can suggest suspicious abnormalities but cannot by itself diagnose cancer. This article explains what a transvaginal (vaginal) ultrasound shows, which ultrasound findings raise concern, why the test has limits, when further tests are needed, and what patients can expect during the exam. The goal is clear, practical information readers can use when discussing results with their clinician in 2026.
Key Takeaways
- A transvaginal ultrasound can reveal abnormalities that suggest cancer but cannot definitively diagnose it.
- Suspicious ultrasound features like complex ovarian masses or thickened endometrium require further testing such as biopsy or MRI for confirmation.
- The accuracy of a transvaginal ultrasound depends on the operator and equipment, highlighting the need for experienced clinicians during interpretation.
- Additional tests including blood markers and referral to specialists are essential when ultrasound findings raise cancer concerns.
- Patients should receive clear communication about their TVUS results and next steps to reduce anxiety and ensure timely diagnosis.
- Transvaginal ultrasound is a valuable initial tool for detecting possible pelvic cancers but must be combined with histology and advanced imaging for conclusive diagnosis.
What A Transvaginal (Vaginal) Ultrasound Is And How It Works
Fact first: a transvaginal ultrasound (TVUS) uses a probe placed in the vagina to create real-time images of pelvic organs. The probe emits sound waves that reflect off tissues: a computer converts echoes into images of the uterus, endometrium, cervix, ovaries, and fallopian tubes.
How it works in practice: the clinician covers the thin probe with a sterile sheath and applies lubricant. Sound frequencies are higher than abdominal ultrasounds, so TVUS shows finer detail of the endometrium and ovarian surface. It measures organ size, wall thickness, and can distinguish fluid-filled cysts from solid tissue by differences in echo patterns.
Concrete example: a 54-year-old woman with postmenopausal bleeding may have an endometrial thickness measured in millimeters: clinicians often use thresholds such as about 4–5 mm to decide if sampling is needed. TVUS also captures blood flow with Doppler: increased vascularity in a mass can raise suspicion.
Limitations built into the method: TVUS is operator-dependent, image quality varies with the technician’s skill and the machine model. It excels at detection but not at definitive tissue characterization.
What Transvaginal Ultrasound Commonly Detects: Benign Versus Suspicious Findings
Fact first: most findings on TVUS are benign, but certain features appear suspicious and prompt further workup.
Common benign findings: simple ovarian cysts (thin-walled, anechoic fluid), uterine fibroids (well-defined solid masses), small functional follicles, and mild endometrial thickening related to hormones. For example, a routine scan in reproductive-aged women often shows one or two small follicles under 3 cm, normal and expected.
Suspicious features: complex ovarian masses with solid components, septations, or papillary projections: markedly thickened or irregular endometrium in a postmenopausal patient: and a clearly defined cervical or uterine mass distorting normal anatomy. These raise concern because they statistically correlate more often with malignancy than simple cysts.
Risk context matters: a 67-year-old with a complex ovarian mass and ascites has a higher pretest probability of cancer than a 28-year-old with a 4 cm simple cyst. TVUS findings are interpreted alongside age, symptoms (like postmenopausal bleeding), family history, and blood tests.
Practical note: when clinicians say a mass looks “suspicious” on ultrasound, they mean it has features that justify biopsy or referral, not that cancer is confirmed.
Ultrasound Signs That May Suggest Cancer
Fact first: specific ultrasound patterns increase suspicion for particular cancers, but they remain non-diagnostic.
Ovary, possible ovarian cancer: ultrasound may show a complex mass with solid areas, irregular borders, internal septations, papillary projections, ascites (free fluid), and increased blood flow on Doppler. In one series, solid components and papillary nodules raised malignant odds significantly compared with simple cysts. Yet many complex masses still prove benign after surgery.
Uterus, possible endometrial cancer: in women with postmenopausal bleeding, an endometrial thickness roughly above 4–5 mm often triggers endometrial sampling. A heterogeneous or irregular lining, or focal masses, amplify concern. Example: an endometrial echo of 12 mm in a 62-year-old requires tissue sampling to exclude malignancy.
Cervix, possible cervical cancer: a visible cervical mass or distortion of cervical shape on TVUS suggests further evaluation. MRI usually follows to stage tumors, but TVUS can detect many cervical lesions.
Bottom line: these signs suggest cancer is possible: confirmation always requires histology.
Limitations: Why Ultrasound Alone Cannot Confirm Cancer
Fact first: ultrasound cannot determine cell-level features and hence cannot confirm cancer.
Why this matters: imaging shows shape, size, and internal patterns, but not cellular behavior. A solid-looking ovarian mass might be a benign fibroma or a malignant tumor, only biopsy or surgical pathology can tell the difference.
Specific limits and numbers: TVUS has high sensitivity for detecting pelvic masses but lower specificity. In screening trials for ovarian cancer, adding TVUS to blood markers produced many false positives, leading to unnecessary surgeries without clear mortality benefit. For example, large screening studies showed low positive predictive value, meaning most positive screens were not cancer.
Practical vulnerability: clinicians sometimes over-interpret reassuring ultrasound appearances, leading to false reassurance. Conversely, benign conditions (endometriomas, hemorrhagic cysts) can look alarming to less experienced eyes and lead to avoidable anxiety or procedures. Patients should expect honest uncertainty from their clinician when TVUS findings are indeterminate.
When Additional Tests Are Needed: Biopsy, MRI, Blood Markers And Referral Pathways
Fact first: biopsy or surgical pathology is the definitive test: imaging and blood tests guide the need for it.
Biopsy options: endometrial sampling (pipelle) or directed cervical biopsy yields tissue for histology. For ovarian lesions, surgical removal and pathology are typically required because percutaneous biopsy risks spreading cells.
Advanced imaging: MRI gives superior soft-tissue contrast and helps stage uterine and cervical tumors. CT scans assess distant spread. MRI can change management, for instance, showing myometrial invasion depth in endometrial cancer, which alters surgical planning.
Blood markers and limits: CA-125 is the most used ovarian cancer marker. Elevated CA-125 plus suspicious TVUS raises concern, especially in postmenopausal women, but CA-125 often rises in benign conditions (endometriosis, menstruation, fibroids) and may miss early disease.
Referral pathways: suspected malignancy usually prompts referral to a gynecologist or gynecologic oncologist. Timelines vary: urgent referral within days for a rapidly growing mass or significant bleeding: routine referral within weeks for indeterminate findings. Clear communication, what was seen, recommended next steps, and expected timing, reduces patient anxiety and speeds diagnosis.
What To Expect During The Exam, Preparation, And How Results Are Communicated
Fact first: the exam is brief (10–20 minutes) and requires minimal preparation, typically an empty bladder.
Preparation and procedure: the patient undresses from the waist down and lies on an exam table. The provider covers the probe, applies lubricant, and inserts it gently into the vagina. The sonographer may ask the patient to change position to image ovaries or uterus fully. Most people feel pressure rather than sharp pain: severe pain should be reported immediately.
Interpretation and timing: a radiologist or gynecologist reviews images and issues a written report. Preliminary impressions may be given immediately, but finalized reports and recommendations usually arrive within days to one or two weeks. Results are communicated by the ordering clinician, who explains whether the finding is normal, benign, or suspicious and what follow-up is needed.
Real example: a patient with a 5 cm complex ovarian mass received same-day counseling that the lesion was indeterminate, CA-125 was ordered, and a gynecologic oncology referral was arranged within a week. That pathway prioritized speed while avoiding premature surgery.
Practical advice: ask for copies of the report and images, note who will call with results, and request written next-step options. Clear expectations reduce confusion and speed care.
Conclusion
Key takeaway: ο κολπικος υπερηχος δειχνει καρκινο is a useful question, TVUS can detect abnormalities that suggest cancer, but it cannot prove cancer. Definitive diagnosis depends on biopsy, and often MRI or blood markers guide next steps. Patients should expect transparent communication, timely referrals when findings are suspicious, and a clear plan for tissue diagnosis if needed.